Optical Imaging, Ltd. revenue stage medical device company focused on clinical markets.
It is currently addressing ophthalmic market needs by providing equipment for early diagnosis, targeted treatment and treatment monitoring.

It’s Retinal Function Imager (RFI) and Brain Imager 3001 systems are based on Optaical Imaging’s proprietary technological innovations which won world-wide recognition because of its unique ability to “see the invisible”.

Using state-of-the-art image acquisition hardware, image processing, and statistical analysis algorithms, Optical Imaging, Ltd. is dedicated to developing and introducing to the medical community novel diagnostic equipment that supplement and will gradually replace the current gold standard.


  • Functional Mapping based on Calcium Probes at the Population Level, based on Organic Probes, or based on Genetically Engineered Probes.
  • Brain Mapping based on Intrinsic Signals (ISI), Including Intrinsic Fluorescence like Flavo-Proteins.
  • Voltage Sensitive Dye Imaging (VSDI) In-vitro, In-vivo.
  • Mapping Blood Flow-Velocity in the Retina
  • Noninvasive Capillary Perfusion Mapping in the Retina.
  • Metabolic Signal Imaging of the Retina.
  • Oxymetry-Like Imaging of the Retina.
  • Multi-Spectral Imaging of the Retina.